Dental conditions in rheumatic diseases. by Esquivel Valerio, Jorge A. et al.
Revista Mexicana de Estomatología
Vol. 3 No. 2  Julio - Diciembre 2016
ISSN: 2007-9052
http://remexesto.com
I
75
Dental conditions in rheumatic diseases.
Afecciones odontológicas en enfermedades reumáticas.
Revisión bibliográfica 
Jorge A. Esquivel Valerio1, Mario Alberto Garza Elizondo3, Jacqueline Rodríguez Amado2, 
Myriam Angélica De La Garza-Ramos4.
1 Médico, Cirujano Partero, Especialista en Medicina Interna con Subespecialidad en Reumatología e Inmunología Clínica, 
Doctorado en Medicina, Catedrático de Reumatología e Investigador del Servicio de Reumatología e Inmunología Clínica 
del Departamento de Medicina Interna, Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Uni-
versidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
2 Catedrática e Investigadora del Servicio de Reumatología e Inmunología Clínica del Departamento de Medicina Interna, 
Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Mon-
terrey, Nuevo León, México.
3 Médico, Cirujano Partero, Especialista en Medicina Interna con Subespecialidad en Reumatología e Inmunología Clínica, 
Doctorado en Inmunología y Jefe del Servicio de Reumatología e Inmunología Clínica del Departamento de Medicina In-
terna, Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, 
Monterrey, Nuevo León, México.
4 Doctorado en Ciencias, Profesora de Odontología y Coordinadora de Investigación de Pregrado, Universidad Autónoma 
de Nuevo León, Facultad de Odontología/Centro de Investigación y Desarrollo en Ciencias de la Salud/Unidad de Odon-
tología Integral y Especialidades,Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
Abstract
Objectives. Review oral manifestations of rheumatic diseases since these can be a diagnostic cha-
llenge.
Procedures. We performed a PubMed search using terms of rheumatic diseases, autoimmune disease
and oral manifestations and also reviewed related guidelines and classifications.
Results. We describe the clinical presentations of rheumatic diseases, such as scleroderma, rheumatoid
arthritis, Sjögren's syndrome, Systemic lupus erythematosus and others that present specific oral ma-
nifestations. We also review the association between periodontal disease and autoimmunity that has
been recently described in the literature.
Conclusions. The oral manifestations of rheumatic diseases are diverse and can represent a challenge
for medical and dental professionals.
Keywords: scleroderma, systemic lupus erythematosus, rheumatoid arthritis, autoimmune disease, pe-
riodontal disease, oral cavity.
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Resumen
Objetivos. Revisar las manifestaciones bucales de las enfermedades reumáticas, ya que estas pueden
ser un reto diagnóstico.
Procedimientos. Se realizó una búsqueda en PubMed utilizando términos de enfermedades reumáticas,
enfermedades autoinmunes y manifestaciones orales y también se revisaron directrices y clasificacio-
nes relacionadas.
Resultados. Describimos las presentaciones clínicas de enfermedades reumáticas, como escleroder-
mia, artritis reumatoide, síndrome de Sjögren, lupus eritematoso sistémico y otros que presentan ma-
nifestaciones orales específicas. También revisamos la asociación entre la enfermedad periodontal y
la autoinmunidad que se ha descrito recientemente en la literatura.
Conclusiones. Las manifestaciones orales de las enfermedades reumáticas son diversas y pueden re-
presentar un reto para los profesionales médicos y odontológicos.
Palabras clave: escleroderma, lupus eritematoso sistémico, artritis reumatoide, enfermedad autoin-
mune, enfermedad periodontal, cavidad oral.
INTRODUCTION
Patients with rheumatic diseases present multiple oral manifestations. These diverse disorders primarily
involve structures of the musculoskeletal system with varying degrees of disability, from mild limitations
to life threatening disease. In this review, we describe some of these manifestations and also review
the association between periodontal disease and autoimmunity. The diseases reviewed were chosen
because of their diverse oral signs and symptoms, which can be a diagnostic challenge for medical
professionals.
Examination of the mouth and gums can represent a challenge for most physicians because of the wide
range of local and systemic processes that can be present. Dentists have better training in the recog-
nition of oral lesions but in their daily practice they limit physical examination to the head and oral cavity.
Also, they sometimes lack knowledge of autoimmune diseases.
METHODS
We performed a PubMed search using the terms scleroderma, systemic lupus erythematosus, rheu-
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matoid arthritis, autoimmune disease and oral manifestations. We also carried out a review of guidelines
and classifications related to these rheumatic diseases and their treatment. Clinical manifestations that
can occur in the oral cavity because of specific therapies were also taken into consideration.
Oral Conditions in Rheumatic Diseases
Systemic scleroderma (SCD) is characterized by the thickening and tightening of the skin in addition to
inflammation of body organs. Its prevalence varies according to different studies in populations, although
it most commonly affects women between 30 and 50 years of age. Hardening of the skin of the fingers
(sclerodactyly) and edema and/or hardening of the skin of the face, neck, trunk and extremities are
common manifestations. In later stages of the disease, skin furrows that radiate from the mouth and
thinning of the vermilion are typical. Telangiectasia can also be detected on the face and even on the
tongue and cheeks. Patients with SCD have great difficulty opening their mouths wide1. (Table 1)
Raynaud's phenomenon is a paroxysmal vasospasm caused by exposure to cold or emotional stress
that affects many patients with SCD and systemic lupus erythematosus (SLE). It presents as pallor,
cyanosis, and erythema of the fingers. The dentist may notice this sign in patients when air conditioning
is on2.
Rheumatoid arthritis (RA) is a chronic inflammatory, systemic disorder of unknown etiology that predo-
minantly affects diarthrodial joints. Its annual incidence is approximately 12 cases/100,000 population.
The disease is frequent in women between the ages of 35 and 50 years with a prevalence of approxi-
mately 1% 3.
A typical observation in chronic RA is bilateral limitation or ankylosis of the wrists. Also, bilateral limitation
or ankylosis of the temporomandibular joints can be found4. Changes of the tongue are frequently ob-
served. Secondary amyloidosis, which causes infiltration of the salivary glands and tongue that produces
macroglossia, has been reported. Although this clinical manifestation is rare, it can be seen in patients
with longstanding disease5. Patients also show an increased incidence of sicca and secondary Sjögren’s
syndrome6. A recent study shows greater loss of periodontal attachment and alveolar bone in early RA
suggesting that intensive dental care must be established to limit periodontal damage7.
Sjögren's syndrome (SS) is a chronic inflammatory disease characterized by decreased tears and saliva.
It is classified when two of the following criteria are met: a positive serum anti-SSA/Ro and/or anti-
SSB/La (positive rheumatoid factor and ANA titer 1:320), or a labial salivary gland biopsy exhibiting
focal lymphocytic sialadenitis and the presence of keratoconjunctivitis sicca8. It occurs in a primary
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form not associated with other diseases and in a form secondary to rheumatic disease9. The most com-
mon disease associated with secondary SS is rheumatoid arthritis. The clinical manifestations of SS
can be divided into those associated with exocrine gland function and those that are extraglandular10.
A prospective study of 80 patients with primary SS that were followed for a mean of 7.5 years reported
keratoconjunctivitis and/or xerostomia in all patients, with this being the only clinical manifestation in
31%. Extraglandular participation occurred in 25% and non-Hodgkin´s lymphoma occurred in 2.5% 11.
Patients with Sjögren usually have poor oral hygiene. A study of 81 subjects, 21 with primary SS, 29
with secondary SS, and 31 healthy individuals, showed that patients with SS considered their oral health
poor and described dryness of the mouth as intense. The most common symptoms were acid sensitivity
(68%), difficulty eating dry foods (66%), and sensitivity to spicy foods (58%). Dry lips (76%) and tongue
(68%) were also among the most frequent complaints. Cervical and atypical cavities (83%), a fissured
and erythematous tongue (70%) and oral candidiasis (74%) were also reported12.
Another frequent alteration in several rheumatic diseases is ulcers, which have a wide differential diag-
nosis. One of the rheumatic diseases that may present recurrent ulcers in the oral and pharyngeal mu-
cosa is Behçet's disease, a rare autoimmune illness that should be suspected in patients with recurrent
multiple round painful oral ulcers. It should also be suspected if systemic manifestations such as throm-
bophilia, genital ulcers, eye disease, skin lesions, gastrointestinal involvement, neurological disease,
vascular disease, or arthritis are present13, 14.
Systemic lupus erythematosus is a chronic systemic inflammatory autoimmune disease that results
from an alteration of immunoregulation mechanisms caused by an interaction of multiple genetic, envi-
ronmental, and hormonal factors. The prevalence of SLE is currently estimated at 2.9/100,000 to
400/100,000. It is more common in women with a female:male ratio of 9 to 1, but in childhood or after
menopause the ratio is narrower (2:1). SLE seems to be more common in certain racial groups, mainly
Afro-Americans, Hispanics, and possibly Chinese and other Asian populations15. It can occur at any
age but is most common between 20 and 40 years of age. There are a variety of manifestations with
arthralgia, arthritis, and myalgia, but skin manifestations are the most common. Of these, the most typi-
cal and frequent is a "butterfly" rash and lesions caused by photosensitivity16.
Typically the disease affects several organs but not all systems and can proceed with periods of exa-
cerbations and remissions over several years. Antinuclear antibodies have been helpful in its diagnosis,
since 98% of patients are positive.
SLE patients present a variety of oral health manifestations: poor oral hygiene, third-grade caries, and 
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painless superficial ulcers that frequently affect the oral mucosa, lips, and palate17. Also, the SLE patient
can present sicca complex characterized by reduced tear and saliva production18.
Ulcerations of the palate have been reported in patients with Wegener's granulomatosis, an autoimmune
disorder characterized by small vessel vasculitis that is highly associated with anti-neutrophil cytoplas-
mic antibodies (ANCA). Its incidence is undetermined but in some countries ranges between 3–10
cases per 100,000 individuals. Hallmarks of this condition are systemic necrotizing vasculitis, necrotizing
granulomatous inflammation, and necrotizing glomerulonephritis. The etiology of granulomatosis with
polyangitis is linked to environmental and infectious triggers that incite the onset of disease in genetically
predisposed individuals19.
Gingival involvement in Wegener's granulomatosis is a common manifestation that is characterized by
a reddish-purple hyperplasia of the gingiva with petechial hemorrhages, a manifestation described as
“strawberry gingivitis” 20. Oral ulcers can occur in areas of the oral and nasal cavity in early stages. Less
commonly nasal septum perforation or destruction of the nose cartilage resulting in a "saddle nose”
can occur. Oral ulcers can be painful or painless. Patients usually report recurrent episodes of sinusitis
or chronic sinusitis that do not respond to antibiotics. Chronic sinusitis is the presenting symptom in
50% of cases and in 80% during the course of the disease21.
Chronic inflammation of the nasal mucosa is detected in 70% of patients, manifested by a bloody or
purulent nasal discharge and epistaxis. In the pharyngeal mucosa, chronic inflammation causes obs-
truction of the ear canal resulting in chronic serous otitis media or acute suppurative otitis media. In the
tracheal or laryngeal mucosa subglottic stenosis may occur, which in severe cases, can cause stridor
and respiratory failure. The previous data alone or combined with nodular pulmonary infiltrates in a se-
riously ill patient, with abnormal urinary sediment in the absence of urinary infection, and the presence
of symptoms such as fatigue, malaise, multisystem disease, peripheral neuropathy without diabetes
and/or the appearance of skin lesions such as petechiae, palpable purpura, livedo reticularis and ulcers
lead to the diagnosis of vasculitis22. 
ANCA, which produce a pattern called cytoplasmic or c-ANCA with indirect immunofluorescence, have
been particularly helpful in the diagnosis of certain vasculitis, such as those associated with Wegener's
Granulomatous23. Since the dentist is one of the first health care professional to recognize Wegener's
granulomatosis manifestations, it is important to train clinicians to facilitate early diagnosis.
Painless superficial ulcers in the oral mucosa and tongue are mucocutaneous manifestations associated
with reactive arthritis. Reactive arthritis is a spondyloarthropathy that shares features with undifferen-
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tiated spondyloarthritis, ankylosing spondylitis, psoriatic arthritis and spondylitis associated with inflam-
matory bowel disease. Members of this family share certain clinical similarities, especially the presence
of HLA-B27, which occurs in up to 90% of patients with reactive arthritis24. Reactive arthritis usually oc-
curs 2-4 weeks after an infectious event and has been associated with certain sexually transmitted mi-
croorganisms such as Chlamydia trachomatis, and bacterial gastrointestinal dysenteric infections such
as Salmonella, Shigella, Yersinia or Campylobacter. The classic triad is nongonococcal urethritis, con-
junctivitis and arthritis but incomplete forms may occur. Oral lesions can occur anywhere in the oral ca-
vity and present as aphthous-like ulcerations, plaques, and erythematous lesions or depapillation of
the tongue25.
Kawasaki disease or syndrome usually occurs in children with febrile syndrome with 85% of cases pre-
senting in children less than 5 years of age with a mortality of 1% to 2.6%. Its incidence is low, appro-
ximately 70-80 cases/100,000, although in epidemics, this frequency can increase. The appearance of
diffuse erythema of the oral and pharyngeal mucosa, red lips, and a "raspberry tongue" are data that
should orient to the diagnosis. In addition to these symptoms, erythema of the palms and soles, indu-
rated edema in the acute phase, and finally, desquamation, can occur. This disease, also known as
mucocutaneous lymph node syndrome, is one of the most common vasculitis of childhood26 and rarely
occurs in adults. It is usually self-limited with fever and manifestations of acute inflammation that last
an average of 11 days without treatment. However, complications such as coronary artery aneurysms,
depressed myocardial contractility, heart failure, myocardial infarction, arrhythmias, and peripheral ar-
terial occlusion may develop and result in significant morbidity and mortality27.
Another group of autoimmune diseases that share characteristics with those previously described are
autoinflammatory syndromes, also known as familial periodic fever syndromes (FPFS), which are cha-
racterized by attacks of inflammation, apparently without cause, without the presence of autoantibodies
or autoreactive T cells28. These genetic syndromes result from defects in proteins of the innate immune
system. More than ten inherited autoinflammatory syndromes caused by more than 770 different mu-
tations have been identified, although 30% to 70% have not been associated with known diagnostic
mutations29. The most common condition of this type is periodic fever, aphthous stomatitis, pharyngitis,
and adenitis. Another syndrome included in this group is cyclic hematopoiesis, which has very similar
clinical features; however, PFAPA is a syndrome that occurs sporadically. In children with PFAPA
syndrome, periodic fever usually begins between the ages of two and five years with a slight male pre-
dominance and no ethnic or racial preference. Familial cases are rare. In most patients attacks stop
occurring before 10 years of age30. Appearance of periodic oral ulcers in association with periodic fever
and other symptoms could suggest PFAPA syndrome. That is why the pediatric dentist may be the first
healthcare worker to evaluate a child with clinical signs compatible with PFAPA syndrome. Additonally,
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children diagnosed with this condition require systematic oral follow-up to monitor for signs of ulcera-
tion31.
Temporomandibular Joint Disorders
It is rare to find this joint inflamed. When affected, the patient usually complains of pain when eating
because of limitation of mouth opening secondary to pain. Mild inflammation is difficult to detect when
exploring this joint unless it occurs asymmetrically. The joint can be felt by placing a finger in front of
the ear canal and asking the patient to open and close his/her mouth and to move the jaw to look for
evidence of inflammation and tenderness. In some patients, crepitation can be heard and felt, even
when arthritis is not severe.
Disorders of the temporomandibular joint (TMJ) can be classified as intracapsular or extracapsular. Ex-
tracapsular disorders are more common and are collectively known as myofascial pain syndrome of
the masticatory muscles. A common name for this disorder is TMJ syndrome. TMJ syndrome is cha-
racterized by acute or chronic musculoskeletal pain, with dysfunction of the masticatory system. It is
aggravated by jaw movement, but is distinct from dental disease. Myofascial pain of the masticatory
muscles presumably occurs because of persistent, unconscious, repetitive use of the muscles involved
32. Regarding intracapsular causes, the diseases that most often affect the TMJ are RA33, degenerative
osteoarthritis34, ankylosing spondylitis35, and juvenile rheumatoid arthritis (JRA)36. If inflammation persists
without proper treatment, decreased bone growth, which results in severe micrognathia, can occur.
Functional disorders of the TMJ are the most common cause of temporomandibular joint pain37. Bruxism
is another little-known cause38. These and other conditions of the temporomandibular joint involve oro-
facial pain and reduced mandibular function, which are common conditions in the general population.
Factors such as bruxism, aggravated by stress or trauma, can accelerate the emergence of joint disor-
ders32.
Jaw claudication, manifested by fatigue of the mastication muscles, has been described in temporal ar-
teritis, also called giant cell arteritis, a large vessel vasculitis that frequently occurs in elderly Caucasians.
This disease may develop with headache, fever, fatigue and malaise. Its incidence is 6.7/100,000/year
but in individuals over 50 years it is 18.3/100,000. It has been associated with HLA-DR4 and CW339.
Patients with headache, jaw claudication when eating, talking or chewing, with or without tongue clau-
dication, masticatory muscle pain and reduction of jaw opening, should be referred to a rheumatologist
for a complete evaluation. In this condition, there is a high erythrocyte sedimentation rate of 70 to 100 
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mm/hour, anemia, and a high C-reactive protein level40.
Drugs that can cause dental disorders
In addition to the autoimmune processes or the symptoms of rheumatic diseases, the use of drugs
aimed at controlling an underlying disease and its symptoms (NSAIDs, glucocorticoids, disease modif-
ying antirheumatic drugs [DMARDs] and immunosuppressants) may produce adverse effects such as
ulcers, mucositis, gingivitis, stomatitis, and gingival bleeding.
Methotrexate, for example, at high doses, may cause mucositis41. The use of penicillamine can cause
taste disturbances or even ageusia42. The use of gold salts is associated with the presence of cheilitis.
Steroids at high doses as well as DMARDs predispose to infection by opportunistic pathogens such as
Candida albicans. Gingival hyperplasia has been observed in patients treated with cyclosporin A43. Re-
lapses or outbreaks of herpes sores may be more frequent with the use of corticosteroids or immuno-
suppressants.
Osteonecrosis of the jaw (ONJ) has been associated with the use of bisphosphonates44, medications
that are used in the treatment of osteoporosis secondary to corticosteroid use and that of postmeno-
pausal origin and in the treatment of various conditions such as the hypercalcemia of cancer and Paget's
disease. Recently, the medical community has been warned of this adverse event, which although rare,
is devastating45.
Bisphosphonates are drugs that affect bones by altering the function of osteoclasts. A review of ninety-
nine cases of ONJ among patients who were prescribed a bisphosphonate for an indication other than
cancer included 85 patients with osteoporosis, 10 patients with Paget's disease, two patients with RA,
a patient with diabetes, and one with fibrous dysplasia of the maxilla. Mean age was 69.4 years, 87.3%
were women and 83.3% were receiving an oral bisphosphonate. A dental procedure was performed in
88.9% before the onset of osteonecrosis of the jaw. Seventy-one percent were taking at least one me-
dication that affects bone turnover, in addition to bisphosphonates, and 81.3% reported other underlying
health conditions. Thus, multiple factors likely influence its pathogenesis46; however, a previous history
of tooth extraction is an important factor.
In another study, the frequency of ONJ in patients with osteoporosis, especially with weekly oral alen-
dronate was 1 in 2,260 to 8,470 (0.01% to 0.04%) patients. If extractions were carried out, the calculated
frequency increased significantly to 1 in 296 to 1,130 cases (0.09% to 0.34%). The total dose of oral 
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alendronate in the presence of ONJ was 9,060 mg. The frequency of ONJ in cases of Paget's disease
was 0.26% to 1.8%. If extractions were carried out, the calculated frequency of ONJ increased from
2.1% to 13.5%. The frequency of ONJ in cases of bone malignancy with intravenous pamidronate or
zoledronate treatment was 0.88% to 1.15%. If extractions were carried out, the calculated frequency of
ONJ was 6.67% to 9.1%. The total dose of pamidronate was 3,285 mg (± 2,530) and 62 mg of zoledro-
nate (± 54.28) at the onset of ONJ. The median time to onset of ONJ was 12 months for zoledronate,
and 24 months for pamidronate and alendronate47. It may be advisable to perform dental procedures
before prescribing bisphosphonates.
Periodontitis and Autoimmune Disease
An association between rheumatic disorders and inflammatory mechanisms is suggested by their
physiopathological resemblance. In recent years, new evidence supports the concept that oral and in-
testine microbiome can play an active role in triggering rheumatic diseases48. Periodontitis is an inflam-
matory condition associated with localized infection that directly affects the teeth and supporting
structures. Multiple studies have demonstrated the involvement of autoimmune processes in periodontal
disease. The presence of auto-antibodies directed against modified type I and III collagen, and anti-
cyclic citrullinated peptide (aCCP) antibodies or autorreactive T lymphocytes in patients with aggressive
periodontitis has been reported49. An association between RA and periodontitis has been reported by
multiple groups50, 51 with infection often being caused by Porphyromona gingivalis, which is credited
with protein citrullination52, generating auto-antigens derived from extracellular soluble protein such as
fibrinogen, alpha-enolase, collagens or vimentin and promoting an autoimmune response in RA53. Re-
cent studies have evidenced the presence of P. gingivalis DNA in blood and synovial tissue54 or that
periodontal treatment decrease aCCP antibodies in RA patients55. Although it has been observed that
RA patients often present with periodontal disease, its presence has not been associated with disease
activity or severity56. Surprisingly, in a recent pilot study conducted at the Universidad Autónoma de
Nuevo León in Monterrey, México (unpublished data), it was found that 40% of patients with RA were
molecular test positive for B. forsythus (Tannerella forsythensis), a bacterium of the red complex of pe-
riodontal pathogens. This preliminary result indicates a strong relation between periodontal disease
and RA. In a similar context, recent efforts have been done to associate periodontal microbioma with
aCCP and RA pathology57.
Other diseases have been associated with periodontal disease: JRA, where a higher prevalence of pe-
riodontal disease has been reported in comparison with a control population58; also, an association bet-
ween JRA, chronic periodontitis, and HLA-DRB3 has been reported59. In systemic sclerosis (SS), 
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characterized by excess collagen production and intense fibrosis of the skin, an increase in the perio-
dontal space (with the most affected areas being the molar and premolar areas in comparison with the
incisor area), tooth loss, difficulty swallowing and other oral sequelae-including microstomia, oral mu-
cosal/gingival fibrosis and xerostomia, have been observed60.
CONCLUSION
Systemic autoimmune diseases present many oral manifestations that can be difficult to identify and
manage depending on the characteristics of the disease. Medical professionals should carefully evaluate
these patients to provide the best available treatment but they should also consider effects caused by
the drugs they use to treat these illnesses since these can also cause lesions in the oral cavity or mu-
cosa.
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Disease Rheumatic manifestations Oral manifestations
Ankylosing spondylitis Arthritis Intracapsular TMJ inflammation
Behçet's disease Thrombophilia, papulopustular le-
sions, Joint arthritis, increased γ
λT cell.
Multiple round painful oral ulcers,
pharyngeal mucosa ulcers
Giant cell arteritis Large vessel vasculitis, concomi-
tant polymyalgia rheumatica
Jaw claudication, masticatory
muscle pain, reduction of jaw ope-
ning
Kawasaki disease Childhood vasculitis, Fever,
Acute inflammation
Diffuse erythema of the oral and
pharyngeal mucosa, red lips,
"Raspberry tongue"
PFAPA syndrome Familial periodic fever syndro-
mes, Aphthous stomatitis, Adeni-
tis 
Pharyngitis, periodic oral ulcers
Reactive arthritis Undifferentiated spondyloarthri-
tis, Ankylosing spondylitis, Pso-
riatic arthritis
Ulcers in the oral mucosa and ton-
gue, diverse oral lesions
Rheumatoid arthritis Chronic joint inflamation, Swollen
joint count, Elevated levels of au-
toantibodies, Elevated levels of
autorreactive cells, Elevated le-
vels of citrullinated synovial pro-
teins
Periodontitis, infection by P. gingi-
valis, gingival overgrowth, di-
sease-associated periodontitis,
macroglossia in long onset pa-
tient, intracapsular TMJ inflamma-
tion, ulcerations, sicca symptoms
Scleroderma Sclerodactyly, edema, hardening
of the skin of the face, telangiec-
tases
Difficulty in opening the mouth
wide, face skin edema, telangiec-
tases in skin face and tongue,
thinning and stiffness of the face
Sjögren's syndrome Sicca syndrome, elevated levels
of autoantibodies, increased con-
centration of serum IgG
Sicca syndrome (keratoconjuncti-
vitis and xerostomía), poor oral hi-
giene, acid sensitivity, difficulty
eating dry foods, sensitivity to
spicy foods, dry lips and tongue,
cervical and atypical cavities, oral
Candidiasis
Systemic Sclerosis Excessive collagen production,
high skin fibrosis
Increase in the periodontal space,
tooth loss, difficulty swallowing,
microstomia, oral mucosal/gingi-
val fibrosis, xerostomia
Table 1. Association between rheumatic diseases and oral manifestations.
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Systemic Lupus Erythematosus Arthralgia, arthritis, myalgia, skin
manifestations (“butterfly" rash),
Raynaud phenomenon, elevated
levels of autoantibodies, multiple
organ damage
Periodontitis and gingivitis, poor
oral hygiene, third-degree caries,
oral mucosal lesions, TMJ
dysfunction, sicca symptoms,
painless superficial ulcers, pallor,
cyanosis and erythema of the fin-
gers
Wegener's granulomatosis Small vessels vasculitis, elevated
levels of ANCA, systemic necroti-
sing vasculitis, granulomatous in-
flammation, glomerulonephritis,
skin lesions (petechiae, palpable
purpura, livedo reticularis)
Oral and nasal ulcerations, sinusi-
tis, chronic inflammation of the
nasal mucosa, otitis, mucosa sub-
glottic stenosis
TMJ disorders Extracapsular TMJ inflammation,
acute or chronic musculoskeletal
pain, myofascial pain of the mas-
ticatory muscles
Masticatory system dysfunction,
temporomandibular joint inflam-
mation
